These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1379282)

  • 1. Role of endogenous interferon in the high sensitivity of C3H/10T1/2 cells to the antiviral activity of interferon.
    Wybier-Franqui J; Brouty-Boyé D
    J Interferon Res; 1992 May; Spec No():17-22. PubMed ID: 1379282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversibility of the transformed and neoplastic phenotype. I. Progressive reversion of the phenotype of X-ray-transformed C3H/10T1/2 cells under prolonged treatment with interferon.
    Brouty-Boyé D; Gresser I
    Int J Cancer; 1981 Aug; 28(2):165-73. PubMed ID: 6172389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different biological response modifiers on interferon expression in bacterial lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive mouse peritoneal macrophages.
    Di Marzio P; Gessani S; Locardi C; Borghi P; Baglioni C; Belardelli F
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2585-91. PubMed ID: 1701475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon induces an antiviral state in ganglioside-deficient transformed mouse fibroblasts.
    Schiffmann D; Koschel K
    Med Microbiol Immunol; 1981; 169(4):281-9. PubMed ID: 6168900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversibility of the transformed and neoplastic phenotype. IV. Effects of long-term interferon treatment of C3H/10T1/2 cells transformed by methylcholanthrene and SV40 virus.
    Brouty-Boyé D; Wybier-Franqui J; Calvo C; Feunteun J; Gresser I
    Int J Cancer; 1984 Jul; 34(1):107-12. PubMed ID: 6204950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C.
    Cembrzyńska-Nowak M
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):499-502. PubMed ID: 2484831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous interferon (IFN) in patients with acute hepatitis B.
    Boron-Kaczmarska A; Zachoval R; Zachoval V; Deinhardt F
    Acta Med Hung; 1990; 47(1-2):77-80. PubMed ID: 1704122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High sensitivity of C3H mouse embryo-derived cell line to the antiviral activity of interferon.
    Brouty-Boyé D
    Proc Soc Exp Biol Med; 1977 Jul; 155(3):438-9. PubMed ID: 195290
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of human interferon on vesicular stomatitis virus released from bovine embryonic kidney cells.
    Harrell SA; Maheshwari RK; Mohanty SB; Friedman RM
    Am J Vet Res; 1982 Apr; 43(4):565-8. PubMed ID: 6176154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages from endotoxin-hyporesponsive (Lpsd) C3H/HeJ mice are permissive for vesicular stomatitis virus because of reduced levels of endogenous interferon: possible mechanism for natural resistance to virus infection.
    Vogel SN; Fertsch D
    J Virol; 1987 Mar; 61(3):812-8. PubMed ID: 2433468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclic AMP and cyclic GMP on the activity of interferon against herpes simplex virus types 1 and 2, and vesicular stomatitis virus.
    Stanwick TL; Nahmias AJ
    Arch Virol; 1982; 72(4):247-56. PubMed ID: 6180707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased sensitivity to interferon associated with in vitro transformation of X-ray-transformed C3H/10T1/2 cells.
    Brouty-Boyé D; Gresser I; Baldwin C
    Int J Cancer; 1979 Aug; 24(2):261-5. PubMed ID: 489167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The target reaction in the antiviral action of mouse interferon against vesicular stomatitis virus multiplication.
    Hoshino M; Taira H; Hattori S; Kawakita M
    J Biochem; 1987 Mar; 101(3):685-94. PubMed ID: 2439495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of Getah virus for antiviral assay of human interferon].
    Ogiso S; Shirai J; Tuchiya Y; Honda E
    Uirusu; 2005 Dec; 55(2):317-26. PubMed ID: 16557019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversibility of the transformed and neoplastic phenotype. III. Long-term treatment with electrophoretically pure mouse interferon leads to the progressive reversion of the phenotype of X-ray transformed C3H/10T1/2 cells.
    Brouty-Boyé D; Puvion-Dutilleul F; Gresser I
    Experientia; 1982 Nov; 38(11):1292-6. PubMed ID: 6184243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of interferon on glycoprotein and membrane protein of vesicular stomatitis virus released from murine and simian cells.
    Drebot MA; Lee SH; Rozee KR
    J Interferon Res; 1984; 4(2):167-72. PubMed ID: 6205101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse interferon receptors: a difference in their response to alpha and beta interferons.
    Gordon I; Stevenson D; Tumas V; Natham CR
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2777-80. PubMed ID: 6319561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins.
    Wallach D
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of acute and chronic ethanol treatment on interferon production in mice.
    Daniluk J; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):239-46. PubMed ID: 7487360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon production and response to exogenous interferon in two cell lines of mouse brain origin persistently infected with Sendai virus.
    Collins AR; Flanagan TD
    Arch Virol; 1977; 53(4):313-21. PubMed ID: 194551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.